Detalhe da pesquisa
1.
Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial.
J Urol
; 207(1): 61-69, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34433303
2.
Longitudinal follow-up and performance validation of an mRNA-based urine test (Xpert® Bladder Cancer Monitor ) for surveillance in patients with non-muscle-invasive bladder cancer.
BJU Int
; 128(6): 713-721, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33793062
3.
Three-year outcomes after Aquablation therapy compared to TURP: results from a blinded randomized trial.
Can J Urol
; 27(1): 10072-10079, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32065861
4.
Aquablation for benign prostatic hyperplasia in large prostates (80-150 cc): 2-year results.
Can J Urol
; 27(2): 10147-10153, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32333733
5.
Symptom relief and anejaculation after aquablation or transurethral resection of the prostate: subgroup analysis from a blinded randomized trial.
BJU Int
; 123(4): 651-660, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29862630
6.
WATER II (80-150 mL) procedural outcomes.
BJU Int
; 123(1): 106-112, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29694702
7.
Aquablation for benign prostatic hyperplasia in large prostates (80-150 mL): 6-month results from the WATER II trial.
BJU Int
; 124(2): 321-328, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30734990
8.
WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation® vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia.
J Urol
; 199(5): 1252-1261, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29360529
9.
IL-15 Superagonist NAI in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer.
NEJM Evid
; 2(1): EVIDoa2200167, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38320011
10.
Aquablation therapy in large prostates (80-150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3-year trial results.
BJUI Compass
; 3(2): 130-138, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35474721
11.
Validation of an mRNA-based Urine Test for the Detection of Bladder Cancer in Patients with Haematuria.
Eur Urol Oncol
; 4(1): 93-101, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33004290
12.
Two-Year Outcomes After Aquablation Compared to TURP: Efficacy and Ejaculatory Improvements Sustained.
Adv Ther
; 36(6): 1326-1336, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31028614
13.
Aquablation for Benign Prostatic Hyperplasia in Large Prostates (80-150 cc): 1-Year Results.
Urology
; 129: 1-7, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31059728
14.
Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer.
Eur Urol
; 75(5): 853-860, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30553612
15.
An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non-muscle-invasive bladder cancer: Interim results.
Urol Oncol
; 36(10): 440-447, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28755959
16.
Laparoscopic radical prostatectomy: initial 70 cases at a U.S. university medical center.
Urology
; 60(5): 859-63, 2002 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-12429316